Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
BIOSPECIFICS TECHNOLOGIES CORP (BSTC)
Sector: Healthcare; Industry: Biotechnology

BioSpecifics Technologies Corp., a biopharmaceutical company, develops an injectable collagenase clostridium histolyticum for various indications in the United States and internationally. The company offers injectable collagenase for the treatment of Dupuytren's contracture and Peyronie's disease under the XIAFLEX and Xiapex brands. BioSpecifics Technologies Corp. was founded in 1957 and is headquartered in Wilmington, Delaware.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-12-02 Endo International plc 10%-Owner Buy 7,344,955 $88.50 $650,028,518 No
2019-09-10 Wegman Toby 10%-Owner, Director Sell 10,000 $55.17 $551,677 No
2019-06-07 Chao Jennifer M Director Sell 459 $58.55 $26,874 No
2019-06-05 Chao Jennifer M Director Sell 5,511 $57.26 $315,543 No
2019-06-03 CALDWELL PATRICK M Principal Financial Officer Sell 6,000 $58.80 $352,800 No
2019-05-29 Chao Jennifer M Director Sell 3,313 $60.74 $201,232 No
2019-05-24 Wegman Mark N Director Sell 7,800 $61.09 $476,502 No
2019-05-22 Mattila Jyrki Director Sell 18,750 $62.06 $1,163,625 Yes
2019-05-22 Wegman Mark N Director Sell 1,200 $63.70 $76,440 No
2019-05-21 Wegman Toby 10%-Owner, Director Sell 5,500 $64.06 $352,353 No
2019-05-21 Wegman Mark N Director Sell 6,000 $64.04 $384,236 No
2019-05-17 Chao Jennifer M Director Sell 4,000 $63.72 $254,860 No
2019-05-15 Gitman Paul Director Sell 5,000 $65.83 $329,150 No
2018-09-11 Wegman Mark N Director Sell 6,500 $57.52 $373,861 No
2018-09-07 Gitman Paul Director Sell 1,000 $57.64 $57,637 No
2018-08-29 Gitman Paul Director Sell 19,000 $49.72 $944,738 No
2018-08-24 Gitman Paul Director Sell 11,825 $51.17 $605,128 No
2018-08-29 Gitman Paul Director Sell 20,000 $49.73 $994,532 No
2018-08-24 Gitman Paul Director Sell 11,825 $51.17 $605,128 No
2018-08-23 Wegman Mark N Director Sell 8,500 $52.63 $447,322 No
2018-08-17 Estate of Edwin H. Wegman 10%-Owner Sell 57,705 $38.22 $2,205,474 No
2018-08-17 Wegman Toby 10%-Owner, Director Sell 2,500 $51.89 $129,728 No
2018-08-17 Wegman Thomas President Sell 23,592 $51.30 $1,210,294 No
2018-08-15 Wegman Thomas President Sell 23,908 $50.81 $1,214,703 No
2016-12-08 Wegman Thomas President Sell 15,000 $49.54 $743,112 No
2016-11-29 Wegman Thomas President Sell 20,000 $48.16 $963,235 No
2016-12-08 Wegman Thomas President Sell 15,000 $49.54 $743,112 No
2016-11-29 Wegman Thomas President Sell 10,000 $48.08 $480,832 No
2016-11-29 Wegman Toby Director Sell 10,000 $48.08 $480,832 No
2016-11-29 Wegman Thomas President Sell 20,000 $48.16 $963,235 No

Insider Smart

Edesa Biotech, Inc. (EDSA) - President and CEO bought shares of EDSA in late May around $3, two weeks after their purchase, the stock jump to $9, very well timed buy.

Insider Smart

Enphase Energy, Inc (ENPH) - ENPH was $10+ in 15Q1 then dropped to $2 and eventually went under $1. From 15Q4 to 17Q4 it built a 2-year-long base then BOOM! Stock went as high as $70 and likely will make a new high. Catch one or two moves like this you can retire early. One hint before the big move was that CEO and CFO were constantly accumulating, this kind of information is priceless.